tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

GHRS Stock Latest News

Psychedelic: Bright Minds reports results from Phase 2 BMB-101 trial
The FlyPsychedelic: Bright Minds reports results from Phase 2 BMB-101 trial
4d ago
CMPS
DRUG
GH Research to Present Six-Month Safety and Efficacy Data on Inhaled GH001 in Depression at 2026 ACNP Meeting
PremiumCompany Announcements
GH Research to Present Six-Month Safety and Efficacy Data on Inhaled GH001 in Depression at 2026 ACNP Meeting
4d ago
6K
GHRS
GH Research price target raised to $29 from $19 at Needham
PremiumThe Fly
GH Research price target raised to $29 from $19 at Needham
7d ago
GHRS
GH Research price target raised to $39 from $35 at Canaccord
PremiumThe Fly
GH Research price target raised to $39 from $35 at Canaccord
7d ago
GHRS
Midday Fly By: U.S. oil majors rise on Venezuela news, Versant completes spinoff
PremiumThe Fly
Midday Fly By: U.S. oil majors rise on Venezuela news, Versant completes spinoff
7d ago
TM
ALT
GH Research: Pivotal Pathway for GH001 in Treatment-Resistant Depression Supports $35 Target and Reiterated Buy Rating
PremiumRatingsGH Research: Pivotal Pathway for GH001 in Treatment-Resistant Depression Supports $35 Target and Reiterated Buy Rating
7d ago
GHRS
GH Research Wins FDA Clearance to Advance GH001 for Treatment-Resistant Depression
Premium
Company Announcements
GH Research Wins FDA Clearance to Advance GH001 for Treatment-Resistant Depression
8d ago
6K
GHRS
GH Research: FDA Lifts Clinical Hold on GH001, Clearing Path to Phase 3 and Supporting Buy Rating
Premium
Ratings
GH Research: FDA Lifts Clinical Hold on GH001, Clearing Path to Phase 3 and Supporting Buy Rating
8d ago
GHRS
GH Research to seek FDA alignment on Phase 3 program replicating Phase 2b design
PremiumThe Fly
GH Research to seek FDA alignment on Phase 3 program replicating Phase 2b design
8d ago
GHRS
GH Research says FDA lifts clinical hold on GH001
PremiumThe Fly
GH Research says FDA lifts clinical hold on GH001
8d ago
GHRS
GH Research: Phase 3 initiation targeted for 2026
PremiumThe Fly
GH Research: Phase 3 initiation targeted for 2026
8d ago
GHRS
GH Research Sets January 5 Update on IND Status and Phase 3 Plans for Lead TRD Drug GH001
PremiumCompany Announcements
GH Research Sets January 5 Update on IND Status and Phase 3 Plans for Lead TRD Drug GH001
10d ago
6K
GHRS
GH Research to Present Promising Results on GH001 at ACNP 2026
PremiumCompany AnnouncementsGH Research to Present Promising Results on GH001 at ACNP 2026
2M ago
6K
GHRS
GH Research PLC Reports Q3 2025 Financial Results
Premium
Company Announcements
GH Research PLC Reports Q3 2025 Financial Results
2M ago
GHRS
Psychedelic: Atai Beckley, Cybin report quarterly earnings
Premium
The Fly
Psychedelic: Atai Beckley, Cybin report quarterly earnings
2M ago
PBM
ABBV
GH Research: Proactive Regulatory Engagement and Strong Financial Positioning Support Buy Rating
PremiumRatings
GH Research: Proactive Regulatory Engagement and Strong Financial Positioning Support Buy Rating
2M ago
GHRS
Strategic Advancements and Financial Stability Drive Buy Rating for GH Research
PremiumRatings
Strategic Advancements and Financial Stability Drive Buy Rating for GH Research
2M ago
GHRS
GH Research price target lowered to $35 from $40 at H.C. Wainwright
PremiumThe Fly
GH Research price target lowered to $35 from $40 at H.C. Wainwright
2M ago
ABBV
ATAI
Positive Outlook on GH Research Amidst Clinical Challenges and Future Growth Potential
PremiumRatings
Positive Outlook on GH Research Amidst Clinical Challenges and Future Growth Potential
2M ago
GHRS
GH Research to Engage at Stifel 2025 Healthcare Conference
PremiumCompany AnnouncementsGH Research to Engage at Stifel 2025 Healthcare Conference
2M ago
6K
GHRS
GH Research: Stable Financials and Promising Clinical Progress Support Buy Rating
Premium
Ratings
GH Research: Stable Financials and Promising Clinical Progress Support Buy Rating
2M ago
GHRS
Psychedelic: Compass Pathways, GH Research report Q3 earnings
Premium
The Fly
Psychedelic: Compass Pathways, GH Research report Q3 earnings
2M ago
PBM
ATAI

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >